W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER
|
Back to Search Results |
|
Catalog Number ASD37J |
Device Problems
Device Dislodged or Dislocated (2923); Migration (4003)
|
Patient Problem
Foreign Body Embolism (4439)
|
Event Date 11/28/2023 |
Event Type
Injury
|
Event Description
|
The following information was reported to gore: on (b)(6) 2023, this patient underwent endovascular treatment to close a 17.3 mm sized, measured by the stop flow balloon technique, atrial septal defect using gore® cardioform asd occluder(gca device).A 37mm gca device was selected.Upon completion of the occluder locking the physician initiated to remove the retrieval cord.Since a shunt was observed while pulling the retrieval cord, the physician decided to upsize the gca device.Because the retrieval cord was no longer attached to the occluder, a snare catheter was used to remove the occluder.A snare catheter was inserted from the femoral vein, the right atrial disc was grasped, and the occluder was moved to the inferior vena cava.Another snare catheter was then inserted from the jugular vein to grasp the left atrial disk.The occluder was pulled from both sides to release the lock.While inserting the occluder into the sheath on the femoral vein side, the occluder dislodged from the snare and moved to the left atrium; hence, a surgical procedure was required.Reportedly, while preparing the surgical procedure, the occluder moved to the pulmonary artery.The occluder was surgically removed, and the atrial septal defect was closed surgically.The patient tolerated the procedure.
|
|
Manufacturer Narrative
|
Per the gore® cardioform asd occluder instruction for use, in the section ¿potential device ¿ or procedure-related adverse events¿.Adverse events associated with the use of the occluder may include, but are not limited to: device embolism w.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|